The influence of Lactobacillus rhamnosus LC705 together with Propionibacterium freudenreichii ssp. shermanii JS on potentially carcinogenic bacterial activity in human colon

Hatakka, Katja; Holma, Reetta; El-Nezami, Hani; Suomalainen, Tarja; Kuisma, Minna; Saxelin, Maija; Poussa, Tuija; Mykkänen, Hannu; Korpela, Riitta

doi:10.1016/j.ijfoodmicro.2008.09.010

Cited by 98 publications

(43 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Reduction in pain was observed with L. rhamnosusGG (Kim et al 2005). Different studies in adults showed that B. infantis, L. rhamnosusGG and mixture of different probiotics such as L. rhamnosusGG, L. rhamnosusLC705, B. breveBb99 and Propionibacterium freudenreichiiJS were found to be effective in alleviating the symptoms (Hatakka et al 2008). Consumption of Bifidobacterium bifidum MIMBb75 for 4 weeks effectively alleviated global IBS, as well as its related symptoms (Guglielmetti et al 2011).…”

Section: Irritable Bowel Syndrome (Ibs)mentioning

confidence: 93%

Probiotics, prebiotics and synbiotics- a review

Pandey¹,

Naik²,

Vakil³

2015

J Food Sci Technol

950

572

View full text Add to dashboard Cite

The health benefits imparted by probiotics and prebiotics as well as synbiotics have been the subject of extensive research in the past few decades. These food supplements termed as functional foods have been demonstrated to alter, modify and reinstate the pre-existing intestinal flora. They also facilitate smooth functions of the intestinal environment. Most commonly used probiotic strains are: Bifidobacterium, Lactobacilli, S. boulardii, B. coagulans. Prebiotics like FOS, GOS, XOS, Inulin; fructans are the most commonly used fibers which when used together with probiotics are termed synbiotics and are able to improve the viability of the probiotics. Present review focuses on composition and roles of Probiotics, Prebiotics and Synbiotics in human health. Furthermore, additional health benefits like immune-modulation, cancer prevention, inflammatory bowel disease etc. are also discussed.

show abstract

Section: Irritable Bowel Syndrome (Ibs)mentioning

confidence: 93%

Probiotics, prebiotics and synbiotics- a review

Pandey¹,

Naik²,

Vakil³

2015

J Food Sci Technol

950

572

View full text Add to dashboard Cite

show abstract

“…In humans, independent researches have shown that consumption of P. freudenreichii subsp. shermanii JS decreased to different extents fecal azoreductase activity in elderly subjects, β-glucosidase and urease in healthy young men and β-glucuronidase activity of irritable bowel syndrome patients [202,203].…”

Section: Modulation Of the Host And Resident Microbiota Metabolismmentioning

confidence: 94%

Dairy Propionibacteria: Less Conventional Probiotics to Improve the Human and Animal Health

Zárate¹

2012

Probiotic in Animals

View full text Add to dashboard Cite

“…Lactobacilli 167 168 have been extensively investigated for treatment of H. pylori infections. Numerous L. strains, that is, L. gasseri Chen, L. plantarum 18, 167 L. gasseri OLL2716, 168 L. reuteri, 169 L. rhamnosus GG, L. rhamnosus Lc705, Propionibacterium (P.) freudenreichii subsp shermanii Js, 170 L. delbrueckii subsp bulgaricus 48, 144 and GB, 171 L. rhamnosus LC705, P. freudenreichii ssp shermanii JS, 168 L. acidophilus LB, 172 L. plantarum MLBPL1, L. rhamnosus GG and L. lactis 137 possess a neutralising activity against H. pylori.…”

Section: Helicobacter Pylori Infectionmentioning

confidence: 99%

Mechanisms and therapeutic effectiveness of lactobacilli

et al. 2015

View full text Add to dashboard Cite

The gut microbiome is not a silent ecosystem but exerts several physiological and immunological functions. For many decades, lactobacilli have been used as an effective therapy for treatment of several pathological conditions displaying an overall positive safety profile. This review summarises the mechanisms and clinical evidence supporting therapeutic efficacy of lactobacilli. We searched Pubmed/Medline using the keyword ‘Lactobacillus’. Selected papers from 1950 to 2015 were chosen on the basis of their content. Relevant clinical and experimental articles using lactobacilli as therapeutic agents have been included. Applications of lactobacilli include kidney support for renal insufficiency, pancreas health, management of metabolic imbalance, and cancer treatment and prevention. In vitro and in vivo investigations have shown that prolonged lactobacilli administration induces qualitative and quantitative modifications in the human gastrointestinal microbial ecosystem with encouraging perspectives in counteracting pathology-associated physiological and immunological changes. Few studies have highlighted the risk of translocation with subsequent sepsis and bacteraemia following probiotic administration but there is still a lack of investigations on the dose effect of these compounds. Great care is thus required in the choice of the proper Lactobacillus species, their genetic stability and the translocation risk, mainly related to inflammatory disease-induced gut mucosa enhanced permeability. Finally, we need to determine the adequate amount of bacteria to be delivered in order to achieve the best clinical efficacy decreasing the risk of side effects.

show abstract

The influence of Lactobacillus rhamnosus LC705 together with Propionibacterium freudenreichii ssp. shermanii JS on potentially carcinogenic bacterial activity in human colon

Cited by 98 publications

References 24 publications

Probiotics, prebiotics and synbiotics- a review

Probiotics, prebiotics and synbiotics- a review

Dairy Propionibacteria: Less Conventional Probiotics to Improve the Human and Animal Health

Mechanisms and therapeutic effectiveness of lactobacilli

Contact Info

Product

Resources

About